The Bull Rankings scorecard — our quality-growth score is 70.8 / 100, built from three pillars scored 0–100: Quality 77, Growth 68, Value 68 (valuation is judged against sector peers). At today's price, our reverse-DCF read says the market is implicitly betting on free-cash-flow growth of about 0% a year next year, rising to 4% a year by year ten — a gauge of how much optimism is already in the stock.
The thesis
Sprouts Farmers Market is trading at a P/E of 12.5 and a PEG of 1.39, comfortably below the grocery‑store average. Our Bull Rankings model gives it a quality‑growth score of 70.8/100 with Quality 77, Growth 68, and Value 68. The strongest pillar—Quality—shows that the business is already generating $357 million of free cash flow and a ROE of 33.5 %. That starting rate is LOWER than the trailing revenue growth of 7.2 %: the price assumes slower growth than the business just delivered. In other words, the market is pricing in a slowdown. If that slowdown never materializes, the stock is already a bargain.
What the business actually is
Sprouts sells fresh, natural, and organic groceries across the United States. Its stores carry produce, meat and meat alternatives, seafood, deli, bakery, floral, and dairy alternatives—the perishable core that drives foot traffic. Non‑perishables—grocery, vitamins and supplements, bulk items, frozen foods, beer and wine, and natural health and body care—provide steady, high‑margin revenue. The brand’s focus on organic, plant‑based, keto, paleo, non‑GMOs, and gluten‑free products taps a growing health‑conscious consumer base.
Why it can (or can't) keep compounding
Sprouts’ moat is two‑fold. First, its high‑margin, high‑turnover product mix delivers a profit margin of 5.6 % while keeping inventory costs low. Second, the company’s strong free‑cash‑flow generation—$357 million in the trailing twelve months—provides the capital needed for selective expansion and shareholder returns. The “Buying back stock” signal from our model confirms that management is already returning value to shareholders, a practice that tightens the equity base and boosts earnings per share. Competitors struggle to match Sprouts’ scale in the niche of health‑focused groceries; the need for specialized suppliers and the premium on fresh inventory create high entry costs that are hard to replicate quickly.
The valuation question
At $65.42 per share, Sprouts sits near its 52‑week low of $64.75, suggesting a modest upside before the next cycle. The P/E of 12.5 is a Value score of 68, meaning the stock is on the cheap side relative to peers. The market is already pricing in a significant slowdown; if revenue growth stays above 7 %, the stock is undervalued. Conversely, if the business cannot sustain its current growth trajectory, the price may already be too high. The analyst consensus 1‑year target of $95 reflects a more optimistic view, but the current price leaves little room for a 45 % jump without a sharp earnings surprise.
The bear case
The most compelling skeptic points to the debt‑to‑equity ratio of 1.4. A leveraged balance sheet can erode margins if interest costs rise or if the company needs to refinance at higher rates. If debt servicing pressures mount, free‑cash‑flow could shrink, undermining the $357 million figure that underpins the quality pillar. A sharp decline in free cash flow would also invalidate the “Durable high returns” signal, turning the stock into a liability rather than an asset.
What would change our mind
- Free‑cash‑flow falling below $300 million would erode the quality pillar and weaken the case for shareholder returns.
- Revenue growth slipping below 5 % would confirm the reverse‑DCF’s pessimistic outlook and push the valuation further into the negative.
- Debt‑to‑equity rising above 1.6 would signal escalating leverage risk, eroding the moat that protects margins.
If any of these thresholds are breached, the current thesis would need to be revisited.